HALEON UK TRADING SERVICES LIMITED
The company operates as the UK trading and pharmaceutical wholesale subsidiary of Haleon plc, a FTSE 100-listed consumer healthcare group spun out of GSK that owns brands including Sensodyne, Panadol, and Advil.
Get an alert when HALEON UK TRADING SERVICES LIMITED files next
Leroy will email you the moment a new filing lands at Companies House — one short note per filing, nothing else.
Cash
£1.2m
-25.8% vs 2024
Net assets
£48m
+6.1% vs 2024
Employees
—
Average over period
Profit before tax
£5.1m
+7.4% vs 2024
Net assets
2-year trend · vs Consumer Discretionary median
Accounts
2-year trend · Δ = latest vs prior filed period · latest reflected 2025-12-31
| Metric | Trend | 2024-12-31 | 2025-12-31 | Δ vs prior |
|---|---|---|---|---|
| Turnover | £3,897,641,000 | £4,381,802,000 | +12.4% | |
| Operating profit | -£5,240,000 | -£2,624,000 | +49.9% | |
| Profit before tax | £4,773,000 | £5,125,000 | +7.4% | |
| Net profit | £3,483,000 | £3,366,000 | -3.4% | |
| Cash | £1,647,000 | £1,222,000 | -25.8% | |
| Total assets less current liabilities | £45,809,000 | £48,497,000 | +5.9% | |
| Net assets | £45,690,000 | £48,497,000 | +6.1% | |
| Equity | £45,690,000 | £48,497,000 | +6.1% | |
| Average employees | 0 | — | — | |
| Wages | — | — | — | |
| Directors' remuneration | — | — | — |
Values shown as filed in the company's annual accounts. — indicates the figure wasn't present under that line item in that period. The Δ column is the change from the prior filed period as a percentage of |prior|; lines a company doesn't report show —. About these numbers
Ratios
Computed from the line items above — sparklines read oldest → newest
| Ratio | Trend | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating margin | -0.1% | -0.1% | |
| Net margin | 0.1% | 0.1% | |
| Return on capital employed | -11.4% | -5.4% | |
| Gearing (liabilities / total assets) | 94.9% | 90.6% | |
| Current ratio | 1.04x | 1.13x |
Margins divide P&L lines by turnover. Gearing is liabilities over total assets. Current ratio is current assets over creditors falling due within one year. Interest cover is operating profit over absolute finance costs. Sector-distribution context coming next.
Name history
Renamed 1 time since incorporation
- HALEON UK TRADING SERVICES LIMITED 2023-02-17 → present
- GLAXOSMITHKLINE CONSUMER TRADING SERVICES LIMITED 2012-06-21 → 2023-02-17
Audit & accounting basis
- Accounting basis
- IFRS
- Reporting scope
- Standalone (parent only)
- Auditor
- KPMG LLP
- Audit opinion
- Unqualified (clean)
- Going concern
- Affirmed
“Having assessed the principal risks and considered other matters, the Directors are of the opinion that the current level of activity remains sustainable. On the basis of these considerations, the Directors believe that the Company has the ability to continue in operation and to meet its liabilities, as they fall due for at least 12 months from the date of approval of the financial statements. Therefore, it remains appropriate to adopt the going concern basis of accounting in preparing the financial statements.”
Significant events
- “In compliance with the revised regulatory requirements post-Brexit for wholesale distributors of medicinal products, since July 2025, the Company has begun conducting trade through its branch office established in the Republic of Ireland which undertakes the procurement and sale activities of consumer health products within the European Economic Area.”
Auditor, going-concern and subsidiary information is drawn from the narrative of the latest annual accounts. About these numbers
People
5 active · 19 resigned
| Name | Role | Appointed | Born | Nationality |
|---|---|---|---|---|
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Secretary | 2022-04-06 | — | — |
| BAIG, Arshad | Director | 2022-06-30 | Dec 1983 | British |
| HATTEEA, Haider Adam Claude | Director | 2021-11-01 | Feb 1980 | British |
| HALEON UK CORPORATE DIRECTOR LIMITED | Corporate Director | 2022-04-06 | — | — |
| HALEON UK CORPORATE SECRETARY LIMITED | Corporate Director | 2022-04-06 | — | — |
Show 19 resigned officers
| Name | Role | Appointed | Resigned |
|---|---|---|---|
| WHYTE, Victoria Anne | Secretary | 2012-06-21 | 2022-04-06 |
| ARISTIDOU, Antrinkos Andrew | Director | 2019-08-19 | 2020-03-10 |
| BOURGEOIS, Scott Christopher | Director | 2022-06-01 | 2022-12-16 |
| BOX, Jonathan Wilson | Director | 2016-06-17 | 2017-11-30 |
| BURNS, Alan George | Director | 2012-12-13 | 2016-08-01 |
| COOPER, Nicholas Ian | Director | 2021-11-01 | 2022-06-01 |
| COOPER, Nicholas Ian | Director | 2019-09-11 | 2020-03-10 |
| FALLON, Pauline Anne, Dr | Director | 2021-11-01 | 2022-12-16 |
| FOSTER-HAWES, Melanie | Director | 2016-06-17 | 2019-01-15 |
| GREEN, Richard | Director | 2017-11-30 | 2020-03-10 |
| HESTLER, Tobias Hannes | Director | 2019-01-15 | 2020-03-10 |
| LYNCH, Aidan | Director | 2019-04-30 | 2022-06-30 |
| O'HARA, Neil | Director | 2013-03-25 | 2021-12-31 |
| PREECE, Jonathan Paul | Director | 2021-11-01 | 2025-04-25 |
| TEACA, Ana Maria | Director | 2022-12-16 | 2025-03-25 |
| TREN, Nicholas Stephen Rudolph | Director | 2020-03-10 | 2021-12-31 |
| WILLIAMSON, Steven | Director | 2012-06-21 | 2013-11-29 |
| EDINBURGH PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Director | 2012-06-21 | 2022-04-06 |
| GLAXO GROUP LIMITED | Corporate Director | 2012-06-21 | 2022-04-06 |
Ownership
Persons with significant control
| Name | Kind | Nature of control | Notified | Status |
|---|---|---|---|---|
| Haleon Uk Holdings (No.3) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-09-01 | Active |
| Gsk Consumer Healthcare Holdings (No.5) Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2021-06-28 | Ceased 2021-09-01 |
| Prism Pch Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-12-13 | Ceased 2021-06-28 |
| Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2019-07-02 | Ceased 2019-12-13 |
| Glaxosmithkline Consumer Healthcare Holdings Limited | Corporate entity | Shares 75–100%, Voting 75–100%, Appoints directors | 2016-04-06 | Ceased 2019-07-02 |
Filing timeline
Last 20 of 100 total filings
Material constitutional events — rename, articles re-file, resolution
- 2025-02-07 RESOLUTIONS Resolution
- 2025-02-07 MA Memorandum articles
| Date | Type | Category | Description | |
|---|---|---|---|---|
| 2026-08-14 | AA | accounts | Accounts with accounts type full | |
| 2025-09-18 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2025-07-21 | AA | accounts | Accounts with accounts type full | |
| 2025-06-20 | CH01 | officers | Change person director company with change date | |
| 2025-04-25 | TM01 | officers | Termination director company with name termination date | |
| 2025-04-01 | TM01 | officers | Termination director company with name termination date | |
| 2025-02-07 | RESOLUTIONS | resolution | Resolution | |
| 2025-02-07 | MA | incorporation | Memorandum articles | |
| 2024-09-12 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2024-09-11 | CS01 | confirmation-statement | Confirmation statement with no updates | |
| 2024-08-22 | AA | accounts | Accounts with accounts type full | |
| 2023-10-06 | PSC05 | persons-with-significant-control | Change to a person with significant control without name date | |
| 2023-10-05 | PSC05 | persons-with-significant-control | Change to a person with significant control | |
| 2023-09-19 | AA | accounts | Accounts with accounts type full | |
| 2023-09-14 | CS01 | confirmation-statement | Confirmation statement with updates | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH04 | officers | Change corporate secretary company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date | |
| 2023-06-05 | CH02 | officers | Change corporate director company with change date |
Public-record activity
Raw counts from Companies House — last 12–24 months
- Filings
- 1
- Capital events
- 0
- Officers appointed
- 0
- Officers resigned
- 0
last 12 months
last 24 months
last 12 months
last 12 months
Direct counts from the register. No score, no rating — see the Filing timeline for the underlying events.